Clinical Trials Browser

Advanced Endometrial Cancer × pembrolizumab × Clear all

NCT05077215 2025-12-08

Efficacy and Safety of a Repurposed Drug Added to the Combination of Len Plus Pem in Advanced Endometrial Cancer

Phase 3 Not yet recruiting

Advanced Endometrial Cancer

NCT05106127 2025-12-08

Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem

Phase 2 Not yet recruiting

Advanced Endometrial Cancer

NCT06046274 2024-04-30

GEN1046 in Combination With Anticancer Agents for the Treatment of Advanced Endometrial Cancer

Phase 2 Withdrawn

Advanced Endometrial Cancer